On April 5, 2024, Yum! Brands, Inc announced that it has received a shareholder proposal from The Shareholder Commons, on behalf of Amundi Asset Management (lead filer) and H.E.S.T. Australia Ltd. as trustee for HESTA (co-filer), ask that the board of directors institute a policy that the Company (Yum) comply with World Health Organization (WHO) Guidelines on Use of Medically Important Antimicrobials in Food-Producing Animals (WHO Guidelines) 1 throughout Yum?s supply chains. In addition, the Company urged the shareholders to vote against the shareholder proposal at its annual general meeting of shareholders scheduled to be held on May 16, 2024.